Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline CharacteristicsAmerican journal of nephrology, 2017-12, Vol.46 (6), p.462-472 [Peer Reviewed Journal]2017 S. Karger AG, Basel ;ISSN: 0250-8095 ;EISSN: 1421-9670 ;DOI: 10.1159/000484633 ;PMID: 29253846Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trialsBMC medical research methodology, 2024-02, Vol.24 (1), p.39-39 [Peer Reviewed Journal]2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2288 ;EISSN: 1471-2288 ;DOI: 10.1186/s12874-024-02170-0 ;PMID: 38365599Full text available |
|
3 |
Material Type: Article
|
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trialCardiovascular diabetology, 2023-11, Vol.22 (1), p.330-330, Article 330 [Peer Reviewed Journal]2023. The Author(s). ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-023-02027-8 ;PMID: 38017482Full text available |
|
4 |
Material Type: Article
|
A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitorsCell metabolism, 2021-04, Vol.33 (4), p.732-739 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2021.02.016 ;PMID: 33691091Full text available |
|
5 |
Material Type: Article
|
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical ApplicationsCirculation (New York, N.Y.), 2016-09, Vol.134 (10), p.752-772 [Peer Reviewed Journal]2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.116.021887 ;PMID: 27470878Full text available |
|
6 |
Material Type: Article
|
Renoprotective effects of sodium-glucose cotransporter-2 inhibitorsKidney international, 2018-07, Vol.94 (1), p.26-39 [Peer Reviewed Journal]2018 International Society of Nephrology ;Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. ;ISSN: 0085-2538 ;EISSN: 1523-1755 ;DOI: 10.1016/j.kint.2017.12.027 ;PMID: 29735306Full text available |
|
7 |
Material Type: Article
|
Dapagliflozin in Patients with Chronic Kidney DiseaseThe New England journal of medicine, 2020-10, Vol.383 (15), p.1436-1446 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2024816 ;PMID: 32970396Full text available |
|
8 |
Material Type: Article
|
High-Density Lipoprotein Particles and Their Relationship to Posttransplantation Diabetes Mellitus in Renal Transplant RecipientsBiomolecules (Basel, Switzerland), 2020-03, Vol.10 (3), p.481 [Peer Reviewed Journal]COPYRIGHT 2020 MDPI AG ;2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2218-273X ;EISSN: 2218-273X ;DOI: 10.3390/biom10030481 ;PMID: 32245262Full text available |
|
9 |
Material Type: Article
|
Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and TreatmentJournal of the American Society of Nephrology, 2017-04, Vol.28 (4), p.1023-1039 [Peer Reviewed Journal]Copyright © 2017 by the American Society of Nephrology. ;Copyright © 2017 by the American Society of Nephrology 2017 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/asn.2016060666 ;PMID: 28143897Full text available |
|
10 |
Material Type: Article
|
Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE TrialCirculation (New York, N.Y.), 2020-02, Vol.141 (5), p.407-410 [Peer Reviewed Journal]2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.044359 ;PMID: 31707795Full text available |
|
11 |
Material Type: Article
|
Effects of Dapagliflozin in Stage 4 Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2021-09, Vol.32 (9), p.2352-2361 [Peer Reviewed Journal]Copyright © 2021 by the American Society of Nephrology. ;Copyright © 2021 by the American Society of Nephrology 2021 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/asn.2021020167 ;PMID: 34272327Full text available |
|
12 |
Material Type: Article
|
Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized TrialJournal of the American Society of Nephrology, 2020-05, Vol.31 (5), p.1128-1139 [Peer Reviewed Journal]Copyright © 2020 by the American Society of Nephrology. ;Copyright © 2020 by the American Society of Nephrology 2020 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/asn.2019111168 ;PMID: 32354987Full text available |
|
13 |
Material Type: Article
|
Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal FunctionClinical journal of the American Society of Nephrology, 2017-05, Vol.12 (5), p.751-759 [Peer Reviewed Journal]Copyright © 2017 by the American Society of Nephrology. ;Copyright © 2017 by the American Society of Nephrology 2017 ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/cjn.10180916 ;PMID: 28302903Full text available |
|
14 |
Material Type: Article
|
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical SimulationJournal of the American Society of Nephrology, 2019-09, Vol.30 (9), p.1756-1769 [Peer Reviewed Journal]Copyright © 2019 by the American Society of Nephrology. ;Copyright © 2019 by the American Society of Nephrology 2019 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/asn.2019010009 ;PMID: 31292198Full text available |
|
15 |
Material Type: Article
|
Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD TrialDiabetes care, 2021-08, Vol.44 (8), p.1894-1897 [Peer Reviewed Journal]Copyright American Diabetes Association Aug 1, 2021 ;2021 by the American Diabetes Association 2021 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc21-0300 ;PMID: 34183431Full text available |
|
16 |
Material Type: Article
|
HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND StudyThe journal of clinical endocrinology and metabolism, 2021-06, Vol.106 (6), p.1761-1772 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/clinem/dgab075 ;PMID: 33567068Full text available |
|
17 |
Material Type: Article
|
The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58Diabetes care, 2021-08, Vol.44 (8), p.1805-1815 [Peer Reviewed Journal]Copyright American Diabetes Association Aug 1, 2021 ;2021 by the American Diabetes Association 2021 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc21-0076 ;PMID: 34233928Full text available |
|
18 |
Material Type: Article
|
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global ConsortiumAmerican journal of kidney diseases, 2019-02, Vol.73 (2), p.206 [Peer Reviewed Journal]ISSN: 1523-6838 ;EISSN: 1523-6838 ;DOI: 10.1053/j.ajkd.2018.08.013Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Longitudinal TNFR1 and TNFR2 and Kidney Outcomes: Results from AASK and VA NEPHRON-DJournal of the American Society of Nephrology, 2022-05, Vol.33 (5), p.996-1010 [Peer Reviewed Journal]Copyright © 2022 by the American Society of Nephrology. ;Copyright © 2022 by the American Society of Nephrology 2022 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/asn.2021060735 ;PMID: 35314457Full text available |
|
20 |
Material Type: Article
|
Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCELDiabetes care, 2019-02, Vol.42 (2), p.318-326 [Peer Reviewed Journal]2018 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2019 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc18-1871 ;PMID: 30523029Full text available |